Developing quality for life

As a leader in the development of omega-3 products for more than 25 years, Pronova BioPharma believes that a new generation of pharmaceuticals will emerge from modified omega-3 lipids.

The group has a highly qualified research and development team with key expertise covering the disciplines required for drug discovery and early development processes. Its research and development strategy focuses on the early phases of drug development.

The use of external resources is part of the strategy to succeed with new pipeline products. Such resources include both academic and contract research organisations.